| BRD9 |
|---|
|
| Available structures |
|---|
| PDB | Ortholog search: PDBe RCSB |
|---|
| List of PDB id codes |
|---|
3HME, 4NQN, 4UIT, 4UIU, 4UIV, 4UIW, 4XY8, 4Z6H, 4Z6I, 4YY4, 4YY6, 4YYD, 4YYG, 4YYH, 4YYI, 4YYJ, 4YYK, 5E9V, 5F1H, 5F1L, 5F2P, 5F25, 5EU1, 5IGN, 5JI8 |
|
|
| Identifiers |
|---|
| Aliases | BRD9, LAVS3040, PRO9856, bromodomain containing 9 |
|---|
| External IDs | OMIM: 618465; MGI: 2145317; HomoloGene: 82462; GeneCards: BRD9; OMA:BRD9 - orthologs |
|---|
|
|
|
|
|
| Wikidata |
|
Bromodomain-containing protein 9 is a protein that in humans is encoded by the BRD9 gene.
[5]
Structure and interaction
BRD9 contains a bromodomain. It is closely related to BRD7. BRD9 is present in some SWI/SNF ATPase remodeling complexes.[6]
Role in cancer
The BRD9 gene is frequently present in variable copy number in lung cancer.[7]
Small molecule inhibition
Small molecules capable of binding to the bromodomain of BRD9 have been developed.[8][9][10]
See also
Bromodomain
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000028310 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000057649 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Entrez Gene: Bromodomain containing 9".
- ^ Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. (June 2013). "Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy". Nature Genetics. 45 (6): 592–601. doi:10.1038/ng.2628. PMC 3667980. PMID 23644491.
- ^ Kang JU, Koo SH, Kwon KC, Park JW, Kim JM (April 2008). "Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer". Cancer Genetics and Cytogenetics. 182 (1): 1–11. doi:10.1016/j.cancergencyto.2007.12.004. PMID 18328944.
- ^ Fedorov O, Lingard H, Wells C, Monteiro OP, Picaud S, Keates T, et al. (January 2014). "[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains". Journal of Medicinal Chemistry. 57 (2): 462–476. doi:10.1021/jm401568s. PMC 3906316. PMID 24313754.
- ^ Clark PG, Vieira LC, Tallant C, Fedorov O, Singleton DC, Rogers CM, et al. (May 2015). "LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor". Angewandte Chemie. 54 (21): 6217–6221. Bibcode:2015ACIE...54.6217C. doi:10.1002/anie.201501394. PMC 4449114. PMID 25864491.
- ^ Theodoulou NH, Bamborough P, Bannister AJ, Becher I, Bit RA, Che KH, et al. (February 2016). "Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition". Journal of Medicinal Chemistry. 59 (4): 1425–1439. doi:10.1021/acs.jmedchem.5b00256. PMC 7354103. PMID 25856009.